gvtcx

NHS Framework Agreement for the supply of Ranibizumab for the NHS in England

NHS England Published 28 Mar 2023 Find a Tender
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£120,000,000
Statuscomplete
Category (CPV) 33600000
Deadline10 Feb 2023
Contract start1 Apr 2023
Contract end31 Mar 2024
Procedureopen
SME suitableYes
OCIDocds-b5fd17-e7c59f94-d69d-41c8-bee3-a3312c4c93fd

Awards (2)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is £120,000,000.

SupplierValueDateStatus
Biogen shared £70,000,000 31 Mar 2023 active
Thornton and Ross Ltd shared £70,000,000 31 Mar 2023 active

description

Framework agreement to supply Ranibizumab in England

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

3 notices published against this procurement.

PublishedTypeRegimeNotice
9 Jan 2023 Contract notice (F02) Earlier regulations 000563-2023
9 Jan 2023 Tender (tender) · ea3c29a8-6d1b-4321-9189-c7a5cbe92b5c-604025
28 Mar 2023 Award (award) · 37e40062-0a31-44ad-80b6-8d0da6035ef0-628788

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.